C07K 5/101
The side chain containing 2 to 4 carbon atoms
Official title: {the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu}
C07K5/101 (The side chain containing 2 to 4 carbon atoms) appears on 472 US grants and 554 published applications in this corpus.
Search patents in C07K- Granted patents
- 472
- Published applications
- 554
- Assignees
- 366
- Inventors
- 1,303
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 15 | 0 |
| 1999 | 10 | 0 |
| 2000 | 14 | 0 |
| 2001 | 17 | 4 |
| 2002 | 15 | 15 |
| 2003 | 12 | 24 |
| 2004 | 16 | 32 |
| 2005 | 10 | 26 |
| 2006 | 19 | 17 |
| 2007 | 17 | 23 |
| 2008 | 15 | 25 |
| 2009 | 20 | 35 |
| 2010 | 22 | 31 |
| 2011 | 14 | 21 |
| 2012 | 13 | 27 |
| 2013 | 24 | 29 |
| 2014 | 30 | 26 |
| 2015 | 17 | 21 |
| 2016 | 18 | 23 |
| 2017 | 15 | 18 |
| 2018 | 15 | 24 |
| 2019 | 12 | 17 |
| 2020 | 11 | 12 |
| 2021 | 6 | 19 |
| 2022 | 13 | 23 |
| 2023 | 3 | 18 |
| 2024 | 10 | 20 |
| 2025 | 10 | 18 |
| 2026 | 9 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polypeptide compound and use thereof in treatment of enteritis29 Sep 2026US 12,747,267 B2Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd.
- Aqueous peptide programming of the vinylidene fluoride ferroelectric phase29 Sep 2026US 12,747,302 B2Northwestern University
- Cosmetic tetrapeptide, composition and use21 Jul 2026US 12,686,703 B2Sederma
- Labyrinthin-based peptides for cancer immunotherapies and uses thereof16 Jun 2026US 12,655,184 B2LabyRx Immunologic Therapeutics (USA) Limited
- Method for increasing romidepsin production from fermentation broth2 Jun 2026US 12,644,096 B2Pro Farm Group, Inc.
- Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives17 Sep 2026US 2026/0273017 A1Ambrx, Inc.
- Compositions and methods for purifying biological fluids6 Aug 2026US 2026/0225001 A1
- Macrocyclic modulators of disease associated protein misfolding and aggregation6 Aug 2026US 2026/0226658 A1Resq Biotech
- Peptides for regulating glucose23 Jul 2026US 2026/0209288 A1
- Amino acid-benzoic acid oligomers and methods of use thereof for treating cancer9 Jul 2026US 2026/0193173 A1
Most cited
By later US patents
- Antibody compositions for selectively inhibiting VEGF356US 6,342,219 B12002
- Antibody conjugate compositions for selectively inhibiting VEGF181US 6,342,221 B12002
- Redox reversible bipyridyl-osmium complex conjugates126US 7,045,310 B2Roche Diagnostics Operations, Inc. · 2006
- Antibody methods for selectively inhibiting VEGF117US 6,524,583 B1Board of Regents, The University of Texas System · 2003
- Transgenic animal model system for human cutaneous melanoma104US 5,550,316 AFox Chase Cancer Center · 1996